PTSD and Substance Abuse Treatment in Virginia
PTSD and substance abuse are a dangerous combination that requires specialized treatment to break the cycle of trauma and addiction. Many people with post-traumatic stress disorder turn to drugs or alcohol to numb intrusive memories, manage hypervigilance, or escape nightmares and flashbacks.
This self-medication provides temporary relief but ultimately worsens both conditions, as substance use prevents proper trauma processing and increases anxiety, depression, and emotional instability. Alpas Wellness offers comprehensive PTSD and substance abuse treatment, providing a safe environment where patients can heal from trauma while building sustainable recovery from addiction.
Frequently Asked Questions About Addiction and PTSD
Why do people with post-traumatic stress disorder have higher rates of substance use disorder?
Post-traumatic stress disorder significantly increases vulnerability to substance abuse due to self-medication patterns. Studies show that PTSD symptoms like flashbacks, hyperarousal, and intrusive memories drive people to use substances for temporary relief.
After traumatic events, the brain’s stress response system remains overactive, making drug use an appealing escape. Risk factors include the severity of traumatic experiences, lack of social support, and pre-existing mental health disorders. Evidence-based research demonstrates that untreated PTSD symptoms create powerful cravings for substances that temporarily numb emotional pain.
What treatment options are most effective for co-occurring PTSD and addiction?
Integrated treatment programs that address both disorders simultaneously show the best treatment outcomes according to clinical trials and meta-analysis studies. Effective interventions include trauma-focused Cognitive Behavioral Therapy (CBT) combined with substance abuse treatment. Prolonged exposure therapy helps process traumatic memories while maintaining sobriety. Treatment centers offering dual diagnosis programs report higher success rates than those treating disorders separately. Evidence shows that addressing comorbid PTSD early in addiction treatment improves long-term recovery outcomes.
How can I help a loved one struggling with both PTSD and substance dependence?
Supporting someone with co-occurring disorders requires understanding both conditions and encouraging professional help. Connect them with healthcare providers specializing in dual diagnosis treatment for proper assessment and care planning. Avoid minimizing their traumatic experiences or substance use struggles. Learn about PTSD symptoms and addiction patterns to recognize warning signs of crisis. Encourage participation in both inpatient and outpatient treatment programs based on severity.
Mental health disorders require patience and consistent support throughout recovery. Help them find treatment centers experienced in trauma-informed care. Remember that integrated treatment addressing both psychiatric disorders offers the best chance for lasting recovery and improved well-being.
What happens during withdrawal for someone with both PTSD and substance abuse issues?
Withdrawal symptoms often intensify PTSD symptoms, creating additional challenges during early recovery. As substances leave the system, anxiety disorders and hyperarousal typically worsen temporarily. Flashbacks may increase in frequency and intensity without the numbing effects of drugs or alcohol.
Medical supervision during detox is crucial for managing both withdrawal and trauma symptoms safely. Treatment programs use medications and psychotherapy to stabilize patients during this vulnerable period. Increased risk of relapse exists when PTSD symptoms spike during withdrawal. Evidence-based protocols help distinguish between withdrawal symptoms and PTSD exacerbation. Follow-up care must address both conditions to prevent the cycle of self-medication from recurring.
Taylor-Desir, M. (2022). What is posttraumatic stress disorder (PTSD)? American Psychiatric Association; American Psychiatric Association. https://www.psychiatry.org/patients-families/ptsd/what-is-ptsd on May 12, 2025
Morey, R. A., Gold, A. L., LaBar, K. S., Beall, S. K., Brown, V. M., Haswell, C. C., Nasser, J. D., Wagner, H. R., & McCarthy, G. (2012). Amygdala volume changes in posttraumatic stress disorder in a large case-controlled veterans group. Archives of General Psychiatry, 69(11), 1169–1178. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1389371 on May 12, 2025
Berenz, E. C., & Coffey, S. F. (2012). Treatment of Co-occurring Posttraumatic Stress Disorder and Substance Use Disorders. Current Psychiatry Reports, 14(5), 469–477. https://pmc.ncbi.nlm.nih.gov/articles/PMC3466083/ on May 12, 2025
María-Ríos, C. E., & Morrow, J. D. (2020). Mechanisms of Shared Vulnerability to Post-traumatic Stress Disorder and Substance Use Disorders. Frontiers in Behavioral Neuroscience, 14(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC7006033/ on May 12, 2025
María-Ríos, C. E., & Morrow, J. D. (2020). Mechanisms of Shared Vulnerability to Post-traumatic Stress Disorder and Substance Use Disorders. Frontiers in Behavioral Neuroscience, 14(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC7006033/ on May 12, 2025
National Institute of Mental Health. (2024, December). Post-traumatic stress disorder. National Institute of Mental Health. https://www.nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd on May 12, 2025
Sterina, E., Michopoulos, V., Linnstaedt, S. D., Neylan, T. C., Clifford, G. D., Ethun, K. F., Lori, A., Wingo, A. P., Rothbaum, B. O., Ressler, K. J., & Stevens, J. S. (2022). Time of trauma prospectively affects PTSD symptom severity: The impact of circadian rhythms and cortisol. Psychoneuroendocrinology, 141, 105729. https://pmc.ncbi.nlm.nih.gov/articles/PMC9250148/ on May 12, 2025